Maria-Filothei Lazaridou Selected Research

Member 2 Subfamily B ATP Binding Cassette Transporter

8/2020	Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma.
1/2020	Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria-Filothei Lazaridou Research Topics

Disease

6	Neoplasms (Cancer) 01/2021 - 01/2019
3	Melanoma (Melanoma, Malignant) 08/2021 - 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020

Drug/Important Bio-Agent (IBA)

3	MicroRNAs (MicroRNA)IBA 08/2020 - 01/2019
2	HLA Antigens (Human Leukocyte Antigens)IBA 08/2021 - 01/2020
2	Member 2 Subfamily B ATP Binding Cassette TransporterIBA 08/2020 - 01/2020
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020 - 01/2020
1	Histocompatibility Antigens Class IIIBA 08/2021
1	BiglycanIBA 01/2021
1	Histocompatibility Antigens Class IIBA 08/2020
1	Biomarkers (Surrogate Marker)IBA 08/2020
1	Surface Antigens (Surface Antigen)IBA 08/2020
1	Horseradish PeroxidaseIBA 01/2020
1	InterferonsIBA 01/2020
1	LuciferasesIBA 01/2020
1	ParaffinIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Bovine Serum AlbuminIBA 01/2020
1	tapasinIBA 01/2020
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2020
1	Untranslated Regions (Untranslated Region)IBA 01/2020
1	transporter associated with antigen processing (TAP)IBA 01/2020
1	Firefly LuciferasesIBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	AntigensIBA 10/2019
1	AntibodiesIBA 10/2019

Therapy/Procedure

1	Therapeutics 10/2019
1	Immunotherapy 10/2019